Skip to main content

Cigna, CVS bolster EpiPen rivals

Cigna has stopped coverage for $600 EpiPens and CVS Pharmacy has dramatically lowered prices for a competing device with a different brand name.

Lead image for this article

The health insurance company Cigna stopped coverage for $600 EpiPens and pharmacy chain CVS dramatically lowered prices for a competing device with a different brand name, dealing a blow to the EpiPen maker Mylan. (CNBC)

Readers like you make our journalism possible.

Give now